
021-69002515*805
sally.tian@shmoxisw.com
+86-17701657231
+86 17771307089
Yolanda LL Ye,Bruce Guo
We are mainly engaged in product development, production and sales in the fields of microbiology, biomedicine and fine chemicals.10%Avilamycin Premix, 20% Avilamycin Premix, 1% Nosiheptide Premix, 2% Nosiheptide Premix, 4% Nosiheptide Premix Avilamycin API Nosiheptide API
If you are interested in our products, please click the button to contact us!
Contact UsShanghai Moxi Biotechnology Co., Ltd. warmly invites you to participate in VIV Qingdao 2019 Address: No. 3399 Sansha Road, West Coast New District, Qingdao, Shandong, China (Qingdao World Expo City)…
Shanghai Moxi Biotechnology Co., Ltd. participated in the 17th Shanghai World Pharmaceutical Raw Materials China Exhibition (CPHI China 2017) on June 20, 2017 and achieved great success. The exhibition attracted…
The Political Bureau of the CPC Central Committee held a meeting on August 26 to deliberate and approve the “Healthy China 2030” planning outline. Xi Jinping, general secretary of the…